A thyroid function screening programme of admissions to a general psychiatric service was established. Over a 22-week period 588 patients were admitted and thyroid function tests were performed on 336, a screening rate of 57.1%. Initial investigation showed that 21.3% had a total thyroxine outside the range 75-130 nmol/I. On further investigation only 9 patients (1 thyrotoxic, 8 hypothyroid) had confirmed thyroid disease. In 7 of the 9 patients the disease had been clinically suspected. Thus the screening programme identified only 2 unsuspected cases of thyroid dysfunction and we conclude that this level of detection does not warrant a formal screening programme.
Introduction
The association between thyroid disease and psychiatric illness has been recognized for many years. In 1803 a patient of Caleb Hillier Parry's became 'subject to palpitations of the heart and nervous troubles' and two weeks later developed overt thyrotoxicosis with intermittent swelling of the thyroid glandI. Hypothyroidism is related to depressive illness and acute psychosis. The review by Richard Asher", in 1948, of 'mxyoedematous madness' describes the many diverse psychiatric manifestations of hypothyroidism. Thyrotoxicosis is related to anxiety neurosis and, rarely, acute psychotic disturbancesb", Kathol et al. reported that if medical patients are sampled, one-third of newly diagnosed thyrotoxic patients would fulfil the DSM III diagnostic criteria for a major depressive illness s . 6 • Previous studies 7 -10 have attempted to assess the incidence of thyroid dysfunction in psychiatric inpatients by screening selected psychiatric admissions. All reports have noted a high frequency of abnormal laboratory results, in the range of 18%-33%, much higher than seen on community or hospital inpatient screening ll • 12 • If this rate of abnormal laboratory investigations reflected true thyroid dysfunction, then screening of all psychiatric inpatients would be indicated.
The present study investigated the practical aspects of screening psychiatric inpatient admissions to assess the relevance of a formal screening programme for thyroid dysfunction.
Methods
The study was designed to screen all admissions to the Psychiatry Unit, St James's University Hospital, Leeds, over a 22-week period. This unit serves a population of330 000and admits unselected patients ofall age groups to the care of 8 consultant psychiatrists. At the start of the study all junior staff were advised of the aims and designs of the study and special 'screening' blood test cards were issued to all wards. Patients were not selected and all doctors involved in the psychiatry service took part in the study.
Laboratory investigation:
The routine biochemistry laboratory thyroid function screening procedure, a four-tier approach, was used. Initially blood is analysed for total thyroxine (T4) concentration (normal range 53-144 nmol/l). Ifthe result falls within the range 75-130 nmol/l, no further investigations are performed. Ifthe initial T4 is greater than 130 nmol/l, the tri-iodothyronine (T3) concentration (normal range 0.8-2.4 nmol/l) is estimated. If the initial T4 is less than 75 nmol/l, a serum thyroid-stimulating hormone (TSH) concentration (normal range 0-5.5 miu/l) is estimated. If indicated clinically, the thyroid hormone binding capacity (THBC) (normal range 92-117 nmol/l) is measured, and the free thyroxine index (Fr41) and free tri-iodothyronine index (Fr31) calculated by the method of Sheridan et al. 1 3 • Finally, if the laboratory results are still equivocal, a thyrotropin-releasing hormone (TRH) test is performed.
A diagnosis of thyrotoxicosis was made if serum T3, T4, Fr31 and Fr41 were elevated on at least two occasions. A diagnosis of hypothyroidism was made if a low serum T4 and a raised TSH greater than 10miu/l were found on two separate occasions.
Results
During the study period 588patients (age range 18-78 .years) were admitted; thyroid function tests were performed on 336patients, a screening rate of 57.1%. The patients screened were a representative sample of all the patients admitted during the study period. The psychiatric diagnoses (9th International Classification of Disease!") and numbers in each group of diagnosis are shown in Table 1 .
Abnormal results: On initial screening 45 (13.3%) patients had a serum T4 greater than 130nmol/l and 28(8.3%) patients had a serum T4less than 75 nmol/l, Further analysis showed that in only 3 patients was the serum T3 raised; only one patient had thyrotoxicosis confirmed after calculation of Fr41 and Fr31. In 8 patients serum TSH was greater than 30 miu/l, confirming biochemical hypothyroidism. No patient had a TSH within the range 6-30 miu/I. Nine (2.7%) patients had confirmed thyroid disease. In only 2 patients, both with hypothyroidism, was Total 217 371 this detected as a result ofthe screening programme. One patient, aged 44 years, had simple schizophrenia and one patient, aged 51years, a personality disorder. In 7 patients the diagnosis had been clinically suspected by members of the psychiatric staff. Four patients, all with manic depressive psychosis, were taking lithium carbonate, 2 patients had known hypothyroidism (but were not on optimal replacement therapy) and the patient with proven thyrotoxicosis had classical clinical signs.
Discussion
Previous studies investigating the relationship between thyroid disease and psychiatric illness have reported a higher incidence of abnormal serum T4 results than those seen in the current study. It has been recommended that thyroid function screening is a worthwhile procedure'. Many of the abnormal results in these studies, however, reflected a transient disturbance of thyroid function, and in one study" the diagnosis of hypothroidism was not always confirmed biochemically. If only thyroid disease confirmed on further biochemical investigation is considered, then the reported levels of detected thyrotoxicosis range from 0.5 to 2.3% and of detected hypothyroidism from 2.0 to 3.6%. These figures still reflect an increase in prevalence of thyroid dysfunction but reduce the potential benefit to be gained from screening. These studies were performed by small units on a selected group of patients and do not reflect the number of abnormal results expected in a 'working situation'. The current study was designed to assess thyroid function screening as a practical procedure in a large general hospital. Motivation amongst junior hospital staff for screening programmes is difficult and our screening rate of57% probably reflects a typical rate, lower than that seen in small, highly motivated units.
The exact prevalence of untreated thyroid disease in the community is unknown, but estimates are in the range of 30-300 per 100000 for thyrotoxicosis and 30-450 per 100000 for hypothyroidism, with men falling at the lower end of the range and women at the upper end of the rangell.12.IS. For our sample of 336 patients, 0.1-1 cases ofthyrotoxicosis and 1-1.5 cases of hypothyroidism would be expected. Our observed prevalence of thyrotoxicosis matches that expected, but more cases of proven hypothyroidism were detected. Only 2 cases of hypothyroidism were found as a result of the screening programme; in 7 of the cases there was either a past history of thyroid disease or lithium carbonate treatment, and thyroid function tests would have been performed routinely. We consider that this level of detection for clinically unsuspected thyroid disease does not warrant a formal screening programme.
